| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |